promising materials which can be considered for advancing molecular oncological research, in particular when antibodies are less desirable due to their immunogenicity or long production time.
KEYWORDS molecularly imprinted polymers, composite nanoparticles, zebrafish embryos, cancer imaging, human vascular endothelial growth factor Angiogenesis is a physiological process concerned with the formation of new blood vessels, essential for sustained viability and growth of malignant solid tumors 1 . This process ensures an adequate blood supply required by various intracellular machineries within cancer cells, e.g.
systems driving RNA and protein synthesis, intracellular transport, abnormal tumor-specific metabolic pathways, organelles integrity preservation, etc. Many of the mechanisms involved in these processes remain unresolved, but should become amenable to investigation by molecularoncological studies carried out by exploiting nanoMIPs. In particular, nanoMIPs, which possess antibody-like properties, are able to cross the cell membrane. Hence, they bear significant potential in accelerating the development of drugs which targets cellular machineries involved in growth and spread of tumor cells, in sharp contrast to conventional chemotherapy agents, which aim to target tumor DNA. Anti-cancer machinery drugs based on this alternative approach to anti-cancer therapy have been reviewed recently 2 . Amongst the effectors involved in angiogenesis, vascular endothelial growth factor (VEGF) stands out as being the most intensively investigated over the years for its crucial role in this process, both in health and disease 3, 4 . Indeed, VEGF is overexpressed in many invasive cancers (breast, colorectal, gastrointestinal, etc.) 5 .Through its autocrine secretory activity, it stimulates proliferation of tumor cells together with proliferation and differentiation of endothelial cells 3 . Targeting 24, 25 . In this article, we demonstrate for the first time the successful imprinting of the secreted effector of angiogenesis, human VEGF (hVEGF), which has been proven to play a pivotal role in many invasive cancers and types of leukemia. NanoMIPs targeting hVEGF were produced by solid-phase synthesis and coupled to quantum dots (QDs) to enable fluorescent imaging in vivo. Their ability to specifically target hVEGF and homing towards the tumor mass was confirmed in xenotransplantation of human malignant melanoma cells in zebrafish embryos 26 . These new highly fluorescent nanoMIPs can be used for the study of angiogenesis as well as potential imaging tools in cancer diagnostics. Additionally, we performed nanoparticle tracking analysis (NTA) on hybrid nanoprobes and non-functionalized MIPs. Particularly, QD-MIPs showed diameter of 140.0 ± 6.8 nm, whereas MIPs 120.6 ± 10.5 nm diameter ( Figure S1 , Table S3 ). As expected, NTA measurement provided slightly smaller values than the ones detected with DLS, since DLS measures the light scattered from each nanoparticle in the sample as a whole, giving an average measurement. Z potential measurements showed a shift of the surface charge of QD-MIPs (attached) (-11.9 ± 0.8 mV) from the value of non-functionalized MIPs (-27.5 ± 4.8 mV) to the less negative value obtained for free QD (-3.76 ± 2.0 mV), confirming the presence of QDs onto the surface of nanoMIPs ( Figure S1 , Table S3 ). Conversely, QD-MIPs (embedded) were found to present similar surface charge to non-functionalized MIPs (Table S1 ). (Table S1 , Figure 3a) . Similarly, QD-MIPs were also able to bind the whole hVEGF protein.
The graph in Figure 3b shows the binding and dissociation curves after the injection of 40 nM recombinant hVEGF. Furthermore, the binding is highly specific, as exemplified by SPR measurements which demonstrated absence of binding of QDMIPs to a non-target molecule. We decided to focus our attention on a molecule similar in terms of isoelectric point to our whole-sequence target hVEGF (8.5) and cysteine-epitope (8.14); for which we chose the antibiotic vancomycin (8.14). This molecule was not recognized by QDMIPs even at concentrations up to 1 μM (three orders of magnitude higher than the ones used for hVEGF) (Figure 3b -c) . Experiments n= 2.
SPR measurements were also performed using an epitope of the epidermal growth factor receptor (EGFR) as control protein. Interestingly, EGFR is endogenously produced in zebrafish 30 and it is known to be involved in angiogenesis, therefore it could be one of the proteins exposed to QD-MIPs in xenotransplanted zebrafish embryos. Concentrations of EGFR epitope ranging from 97 pM to 100 nM (as per hVEGF epitope and vancomycin) were injected ( Figure S) . The goodness of the fit of data obtained from Biacore measurements was poor and therefore it did not allow calculating any K D , which resulted in the confirmation of specificity of our hybrid nanoprobes for hVEGF template.
SPR measurements allowed us to conclude that QD-MIPs imprinted against hVEGF had high affinity and specificity for the epitope and were able to bind the whole hVEGF.
The next step in our experiments was to assess the ability of QD-MIPs to localize in vivo, namely (Table S2) . Based on these findings, we incubated the nanoprobes for 7 hours in either hVEGF (+) or hVEGF (-) zebrafish models. 
Corresponding Author
Vittoria Raffa v.s.raffa@dundee.ac.uk; Alfred Cuschieri a.cuschieri@dundee.ac.uk
Author Contributions
A.C. prepared and characterized the nanoprobes in vitro and performed the in vivo experiments and confocal microscopy. A.C. wrote the paper. V.R., F.C., G.S. contributed to the experimental activities and to edit the manuscript. All authors discussed the results, contributed to data analysis, and commented on the manuscript. S.P. and A.Cu. designed the experiments and supervised the research.
Funding Sources
The research leading to these results has received funding from the People Programme F.C and S. P. declare competing financial interests.
